Highlights

  • Partnership extension leverages Medidata Experiences to unify clinical trial workflows.
  • The agreement enables Sanofi to strengthen data quality and enhance patient care across studies.
  • Collaboration focused on accelerating global development and delivery of new therapies.

Sanofi (NASDAQ:SNY) and Medidata, a brand under Dassault Systèmes, announced the renewal and expansion of their decade-long partnership to advance clinical research. Under the extended agreement, Sanofi will deploy Medidata Patient, Data, and Study Experiences to connect previously separate clinical trial tools, streamline operational workflows, minimize delays, and improve cost efficiency.

The renewed collaboration builds on earlier partnerships, including their 2024 engagement, and continues to focus on optimizing clinical operations, improving data integrity, and driving better health outcomes.

Management Commentary
Gaelan Ritter, Global Head of Digital Clinical Development at Sanofi, said:
“Through this expanded relationship, we will continue to harness AI to make our clinical trials more efficient and deliver innovative medicines to patients faster.”

Lisa Moneymaker, Chief Strategy Officer at Medidata, stated:
“With this partnership, Sanofi can fully utilize our integrated solutions designed around their key operational needs, simplifying execution and accelerating the entire clinical development process.”

Decentralized Trials and Operational Support
As part of the extended enterprise agreement, Sanofi will gain access to Medidata’s decentralized clinical trial capabilities. Medidata will also provide strategic consulting and comprehensive operational support, helping Sanofi improve research efficiency and speed up the development of new therapies.

Medidata Experiences Platform
Medidata Experiences aims to address the issue of fragmented tools across the life sciences industry. These AI-enhanced, platform-based solutions cover all stages of the clinical trial lifecycle, helping to improve efficiency, reduce silos, and ensure greater precision in study execution. Combined with Sanofi’s expertise in pharmaceuticals, the platform is structured to elevate clinical trial performance and patient outcomes.

Company Overviews
Medidata has supported more than 36,000 clinical trials and 11 million patients globally, offering data-driven insights and hosting one of the industry's most extensive clinical trial datasets.

Sanofi is a global healthcare leader committed to developing therapies and vaccines that improve lives. The company delivers treatments to millions of patients worldwide while upholding sustainability and social responsibility at the heart of its operations.